Opposition 91207462
OtherUSPTO
Opposition 91207462 at USPTO between Metagenics, Inc. and Global Quality Health, Inc., over the mark ENDURAZOL, filed Oct 12, 2012. Status in the office record: other.
- Status
- Other
- Result
- Other
- Filed
- Oct 12, 2012
- Marks involved
- 6
Parties
Who is involved
The parties as named in the office record.
Respondent
Global Quality Health, Inc.
Timeline
How the case has moved
Dates from the USPTO record and the ENDURAZOL filing.
ENDURAZOL filed
Application 85529802 filed at the USPTO.Opposition filed
Metagenics, Inc. started opposition 91207462 at USPTO against ENDURAZOL.
Marks
Marks involved
1 contested mark, 5 marks the challenger relies on.
API
Get this data via the API
Every fact on this page comes from the Signa API. Track oppositions and cancellations on any mark with one request.
GET/v1/proceedings/{id}Parties, dates, outcome and every mark in the case
GET/v1/proceedings?trademark_id={trademark_id}Every proceeding on a mark
GET /v1/proceedings/{id}
ID=prc_6fff38e4-1859-49db-a54a-ced09e3e92e7
curl https://api.signa.so/v1/proceedings/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"Response
{
"id": "prc_6fff38e4-1859-49db-a54a-ced09e3e92e7",
"object": "proceeding",
"proceeding_type": "opposition",
"proceeding_number": "91207462",
"status": "other",
"office_code": "US",
"filed_date": "2012-10-12",
"parties": [
{
"name": "Metagenics, Inc.",
"role": "opponent"
},
{
"name": "Global Quality Health, Inc.",
"role": "respondent"
}
]
}